Methods to predict cholesterol elevations during immunosuppressant therapy

Details for Australian Patent Application No. 2003287955 (hide)

Owner Novartis AG

Inventors Polymeropoulos, Mihael Hristos; Torres, Rosarelis; Wolfgang, Curt Douglas; Kudaravalli, Sridhar

Agent Davies Collison Cave

Pub. Number AU-B-2003287955

PCT Number PCT/EP2003/0107

PCT Pub. Number WO2004/029618

Priority 60/415,123 30.09.02 US

Filing date 29 September 2003

Wipo publication date 19 April 2004

Acceptance publication date 21 June 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/415,123 30.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-B-2003287955

21 June 2007 Application Accepted

  Published as AU-B-2003287955

18 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287956-RETAINING RING FOR HOLDING SEMICONDUCTOR WAFERS IN A CHEMICAL-MECHANICAL POLISHING DEVICE

2003287954-METHOD FOR THE PRODUCTION OF CATALYTICALLY ACTIVE LAYER SILICATES